Does asthma affect morbidity or severity of COVID-19?

Matsumoto, Kenji; Saito, Hirohisa

Matsumoto, Kenji; Saito, Hirohisa.

Afiliação

Matsumoto K; Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan. Electronic address: matsumoto-k@ncchd.go.jp.
Saito H; Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.

J Allergy Clin Immunol ; 146(1): 55-57, 2020 Jul.

Article em En | MEDLINE | ID: mdl-32470485

Assuntos

Asma/epidemiologia; Infecções por Coronavirus/epidemiologia; Pneumonia Viral/epidemiologia; Betacoronavirus; COVID-19; Comorbidade; Humanos; Pandemias; SARS-CoV-2

Palavras-chave

Coronavirus disease 2019; IFN; T2 cytokines; angiotensin-converting enzyme 2; asthma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Asma / Infecções por Coronavirus Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google